Medicure (MCUJF) Cost of Revenue (2009 - 2026)
Medicure's (MCUJF) quarterly Cost of Revenue came in at $3.2 million in Q1 2026, up 75.35% year-on-year from $1.8 million in Q1 2025, and down 23.01% quarter-over-quarter from $4.2 million in Q4 2025.
Medicure (MCUJF) Cost of Revenue (2009 - 2026) Analysis & Trends
Medicure's Cost of Revenue history runs 18 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- On a quarterly basis, Cost of Revenue rose 75.35% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $13.7 million, a 96.91% increase from a year earlier, with the FY2025 full-year figure at $12.2 million, up 90.1% from the prior year.
- Cost of Revenue fell to $3.2 million in Q1 2026 per MCUJF's latest filing, from $4.2 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $4.2 million in Q4 2025 and bottomed at $1.3 million in Q1 2022.
- The 5-year median for Cost of Revenue is $1.8 million (2025), against an average of $2.3 million.
- Across the five-year window, Cost of Revenue tumbled 61.22% in 2023 and soared 138.64% in 2025, its largest moves.
- Year by year, Cost of Revenue stood at $2.1 million in 2022, then fell by 0.29% to $2.1 million in 2023, then slipped by 16.81% to $1.8 million in 2024, then surged by 138.64% to $4.2 million in 2025, then dropped by 23.01% to $3.2 million in 2026.
- Per Business Quant, the three latest MCUJF Cost of Revenue figures stand at $3.2 million (Q1 2026), $4.2 million (Q4 2025), and $3.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 586.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | 3.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.23 Mn |
| Mar 31, 2026 | 3.23 Mn |
| Dec 31, 2025 | 4.19 Mn |
| Dec 31, 2025 | 4.19 Mn |
| Sep 30, 2025 | 3.91 Mn |
| Sep 30, 2025 | 3.91 Mn |
| Jun 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 2.33 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 1.76 Mn |
| Dec 31, 2024 | 1.76 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 1.62 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Dec 31, 2023 | 2.11 Mn |
| Dec 31, 2023 | 2.11 Mn |